Insider Transactions Reported by 14 Insiders of INTELLIGENT BIO SOLUTIONS INC.

Symbol: INBS on Nasdaq
Location: New York, NY

Key facts

INBS - INTELLIGENT BIO SOLUTIONS INC. has 14 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

Change

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 25 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

INTELLIGENT BIO SOLUTIONS INC. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Life Science Biosensor Diagnostics Pty Ltd	Former 10% owner	$2,001,337	Mixed	17 Feb 2022
Ma-Ran Foundation	10%+ Owner	$394,540	Mixed	12 May 2023
Gary W. Rollins Foundation	10%+ Owner	$352,405	Mixed	12 May 2023
Spiro Kevin Sakiris	Chief Financial Officer	$140,337	Mixed	18 Mar 2026
Harry Simeonidis	Chief Executive Officer	$135,051	Mixed	18 Mar 2026
George Margelis	Director	$27,750	Mixed	10 Oct 2022
Lawrence B. Fisher	Director	$27,750	Mixed	10 Oct 2022
Steven Constantine Boyages	Director	$19,671	Mixed	18 Mar 2026
Jonathan Scott Hurd	Director	$19,573	Mixed	18 Mar 2026
Nicola Marion Fraser	Director	$19,550	Mixed	18 Mar 2026
Jason Isenberg	Director	$19,550	Mixed	18 Mar 2026
Christopher Towers	Director	$18,278	Mixed	04 Oct 2023
Tom Parmakellis	Director	$17,205	Mixed	30 Dec 2021
David A. Jenkins	Director		Mixed	04 Oct 2022

Top shareholders of INTELLIGENT BIO SOLUTIONS INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13F 13D/G	Company	10% from 13D/G	130,000	$434,850	—	31 Mar 2026	13F 13D/G
Alyeska Investment Group, L.P.	13F 13D/G	Company	10% from 13D/G	37,956	$126,963	—	31 Mar 2026	13F 13D/G
BIGGER CAPITAL FUND L P	13D/G	Bigger Michael	5%	303,032	$50,000	$0	31 Dec 2024	13D/G
Life Science Biosensor Diagnostics Pty Ltd	3/4/5	Former 10% owner	— class O/S missing	1,081,804	$2,001,337	—	17 Feb 2022	3/4/5
Ma-Ran Foundation	3/4/5	10%+ Owner	— class O/S missing	213,265	$394,540	—	12 May 2023	3/4/5
Gary W. Rollins Foundation	3/4/5	10%+ Owner	— class O/S missing	190,489	$352,405	—	12 May 2023	3/4/5
Spiro Kevin Sakiris	3/4/5	Chief Financial Officer	— class O/S missing	35,892	$140,337	—	18 Mar 2026	3/4/5
Harry Simeonidis	3/4/5	Chief Executive Officer	— class O/S missing	34,540	$135,051	—	18 Mar 2026	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	28,609	$95,696	—	31 Mar 2026	13F
George Margelis	3/4/5	Director	— class O/S missing	15,000	$27,750	—	10 Oct 2022	3/4/5
Lawrence B. Fisher	3/4/5	Director	— class O/S missing	15,000	$27,750	—	10 Oct 2022	3/4/5
Steven Constantine Boyages	3/4/5	Director	— class O/S missing	5,031	$19,671	—	18 Mar 2026	3/4/5
Jonathan Scott Hurd	3/4/5	Director	— class O/S missing	5,006	$19,573	—	18 Mar 2026	3/4/5
Jason Isenberg	3/4/5	Director	— class O/S missing	5,000	$19,550	—	18 Mar 2026	3/4/5
Nicola Marion Fraser	3/4/5	Director	— class O/S missing	5,000	$19,550	—	18 Mar 2026	3/4/5
VANGUARD CAPITAL MANAGEMENT LLC	13F	Company	— class O/S missing	5,810	$19,434	—	31 Mar 2026	13F
Christopher Towers	3/4/5	Director	— mixed-class rows	28,060 mixed-class rows	$18,278	—	04 Oct 2023	3/4/5
Tom Parmakellis	3/4/5	Director	— class O/S missing	9,300	$17,205	—	30 Dec 2021	3/4/5
VANGUARD FIDUCIARY TRUST CO	13F	Company	— class O/S missing	3,958	$13,240	—	31 Mar 2026	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	1,250	$4,181	—	31 Mar 2026	13F
UBS Group AG	13F	Company	— class O/S missing	372	$1,244	—	31 Mar 2026	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	200	$670	—	31 Mar 2026	13F
CURIO WEALTH, LLC	13F	Company	— class O/S missing	200	$669	—	31 Mar 2026	13F

Recent Insider Transactions by Companies or Individuals for INTELLIGENT BIO SOLUTIONS INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Steven Constantine Boyages	INBS	Common Stock	Award	16129%	5,000	5,031	18 Mar 2026	Direct
Nicola Marion Fraser	INBS	Common Stock	Award		5,000	5,000	18 Mar 2026	Direct
Spiro Kevin Sakiris	INBS	Common Stock	Award	876.2%	30,500	33,981	18 Mar 2026	Direct
Jonathan Scott Hurd	INBS	Common Stock	Award	83333.3%	5,000	5,006	18 Mar 2026	Direct
Jason Isenberg	INBS	Common Stock	Award		5,000	5,000	18 Mar 2026	Direct
Harry Simeonidis	INBS	Common Stock	Award	755%	30,500	34,540	18 Mar 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.